Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19. - Prentice RE; Tjandra D; Garg M; Lubel JS; Fourlanos S; Johnson D; Al-Ani A; Christensen B (Alimentary pharmacology & therapeutics, 2020)